Back to results
US 7,582,726 B2Granted
VEGF receptor antagonists
AssigneeGHC Research Development Corporation
InventorsWen Yuan Chen, Jang P. Park
Life of this patent
Estimating the term…
Abstract
The present invention describes an approach to cancer therapy utilizing novel VEGF receptor antagonists. Specifically, the invention provides peptides and polynucleotides encoding VEGF receptor antagonists and methods of use thereof.
Claims5
A VEGF receptor antagonist consisting of KDR (Ig5-7).
A soluble VEGF receptor antagonist that consists essentially of SEQ ID NO:2.
A soluble VEGF receptor antagonist that consists essentially of SEQ ID NO:4.
Dependencies are inferred from the claim text.